Literature DB >> 22613073

Chemical constituents of Anacolosa pervilleana and their antiviral activities.

Mélanie Bourjot1, Pieter Leyssen, Cécilia Eydoux, Jean-Claude Guillemot, Bruno Canard, Philippe Rasoanaivo, Françoise Guéritte, Marc Litaudon.   

Abstract

In an effort to identify novel inhibitors of Chikungunya (CHIKV) and Dengue (DENV) virus replication, a systematic study with 820 ethyl acetate extracts of Madagascan plants was performed in a virus-cell-based assay for CHIKV and a DENV NS5 RNA-dependant RNA polymerase (RdRp) assay. The extract obtained from the leaves of Anacolosa pervilleana was selected for its significant activity in both assays. One new (E)-tridec-2-en-4-ynedioic acid named anacolosine (1), together with three known acetylenic acids, the octadeca-9,11,13-triynoic acid (2), (13E)-octadec-13-en-9,11-diynoic acid (3), (13E)-octadec-13-en-11-ynoic acid (4), two terpenoids, lupenone (5) and β-amyrone (6), and one cyanogenic glycoside, (S)-sambunigrin (7) were isolated. Their structures were elucidated by comprehensive analyses of NMR spectroscopy and mass spectrometry data. The inhibitory potency of these compounds was evaluated on CHIKV, DENV RdRp and West-Nile polymerase virus (WNV RdRp). Both terpenoids showed a moderate activity against CHIKV (EC(50) 77 and 86 μM, respectively) and the acetylenic acids produced IC(50) values around 3 μM in the DENV RdRp assay.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22613073     DOI: 10.1016/j.fitote.2012.05.004

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  14 in total

1.  Anacolosins A-F and Corymbulosins X and Y, Clerodane Diterpenes from Anacolosa clarkii Exhibiting Cytotoxicity toward Pediatric Cancer Cell Lines.

Authors:  Shengxin Cai; April L Risinger; Cora L Petersen; Tanja Grkovic; Barry R O'Keefe; Susan L Mooberry; Robert H Cichewicz
Journal:  J Nat Prod       Date:  2019-03-04       Impact factor: 4.050

2.  Phytoconstituents as Lead Compounds for Anti-Dengue Drug Discovery.

Authors:  Kamatchi Sundara Saravanan; Selvam Arjunan; Selvaraj Kunjiappan; Parasuraman Pavadai; Lakshmi M Sundar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Anti-oral common pathogenic bacterial active acetylenic acids from Thesium chinense Turcz.

Authors:  Chang Liu; Xiao-Tian Li; Rong-Rong Cheng; Zhu-Zhen Han; Li Yang; Zhong-Chen Song; Zheng-Tao Wang
Journal:  J Nat Med       Date:  2018-02-12       Impact factor: 2.343

Review 4.  Chikungunya virus (CHIKV) inhibitors from natural sources: a medicinal chemistry perspective.

Authors:  Soumendranath Bhakat; Mahmoud E S Soliman
Journal:  J Nat Med       Date:  2015-04-29       Impact factor: 2.343

Review 5.  Potential Antivirals: Natural Products Targeting Replication Enzymes of Dengue and Chikungunya Viruses.

Authors:  Ana Flávia Costa da Silveira Oliveira; Róbson Ricardo Teixeira; André Silva de Oliveira; Ana Paula Martins de Souza; Milene Lopes da Silva; Sérgio Oliveira de Paula
Journal:  Molecules       Date:  2017-03-22       Impact factor: 4.411

Review 6.  The medicinal chemistry of Chikungunya virus.

Authors:  Edeildo F da Silva-Júnior; Giovanni O Leoncini; Érica E S Rodrigues; Thiago M Aquino; João X Araújo-Júnior
Journal:  Bioorg Med Chem       Date:  2017-06-29       Impact factor: 3.641

7.  Molecular Modeling and Docking Study to Elucidate Novel Chikungunya Virus nsP2 Protease Inhibitors.

Authors:  T Agarwal; Somya Asthana; A Bissoyi
Journal:  Indian J Pharm Sci       Date:  2015 Jul-Aug       Impact factor: 0.975

Review 8.  Current Strategies for Inhibition of Chikungunya Infection.

Authors:  Bharat Bhusan Subudhi; Soma Chattopadhyay; Priyadarsee Mishra; Abhishek Kumar
Journal:  Viruses       Date:  2018-05-03       Impact factor: 5.048

Review 9.  Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy.

Authors:  Simon-Djamel Thiberville; Nanikaly Moyen; Laurence Dupuis-Maguiraga; Antoine Nougairede; Ernest A Gould; Pierre Roques; Xavier de Lamballerie
Journal:  Antiviral Res       Date:  2013-06-28       Impact factor: 5.970

Review 10.  Intervention strategies for emerging viruses: use of antivirals.

Authors:  Yannick Debing; Dirk Jochmans; Johan Neyts
Journal:  Curr Opin Virol       Date:  2013-04-04       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.